Avivagen Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VIVXF research report →
About the company
Avivagen Inc. is a life sciences firm primarily engaged in creating and distributing specialized feed supplements for livestock. These products are designed to bolster animals' immune function and contribute to their enhanced growth and overall productivity.
- CEO
- G. F. Kym Anthony
- IPO
- 2013
- Employees
- 13
- HQ
- Ottawa, ON, CA
Price Chart
- Market Cap
- $7.77K
- P/E
- -0.11
- P/S
- 0.83
- P/B
- -0.11
- EV/EBITDA
- -2.69
- Div Yield
- 0.00%
- Gross Margin
- 42.62%
- Op Margin
- -99.40%
- Net Margin
- -645.91%
- ROE
- 122.10%
- ROIC
- -916.23%
- Revenue
- $939.17K · -27.53%
- Net Income
- $-6,066,206 · 5.13%
- EPS
- $-0.09 · 23.42%
- Op Income
- $-4,897,756
- FCF YoY
- 32.36%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.36
- Avg Volume
- 86.8
Get TickerSpark's AI analysis on VIVXF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our VIVXF coverage
Recent articles, reports, and earnings notes.
No research on VIVXF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate VIVXF report →Similar companies
Peers in the same neighborhood.